Jiangsu Huaian Mingde Biochemical Technology Co., Ltd. has always been committed to the development of anti-tumor active pharmaceutical ingredients (APIs) and intermediates, primarily operating as a high-tech enterprise focused on the production and sales of anti-tumor drugs. The company's business scope covers multiple fields, including pharmaceutical APIs, pharmaceutical intermediates, and fine chemicals, with its own R&D center and production base. The company has two main product lines: anti-tumor drugs—the TKI series—and Gemcitabine Hydrochloride.